Related Experiment Video
Updated: Jun 25, 2026
06:17
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Amyloid beta-peptide aggregation. What does it result in and how can it be prevented?
Charlotte Nerelius1, Jan Johansson, Anna Sandegren
1Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, the Biomedical Centre, 751 23 Uppsala, Sweden.
Frontiers in Bioscience (Landmark Edition)
|March 11, 2009
Summary
Amyloid beta-peptide (Abeta) aggregation into toxic forms drives Alzheimer's disease. Current research reviews Abeta species and challenges in developing effective aggregation inhibitors for Alzheimer's disease therapeutics.
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Amyloid beta-peptide (Abeta) polymerization forms cytotoxic oligomers and fibrils, linked to Alzheimer's disease (AD) pathogenesis and neuronal damage.
- Despite extensive research, effective therapeutic strategies to prevent Abeta aggregation and treat AD remain elusive.
- The complexity of Abeta aggregation, including undefined oligomeric species and structural polymorphism, hinders the development of targeted treatments.
Purpose of the Study:
- To review current understanding of Abeta monomeric, oligomeric, and polymeric forms.
- To discuss the challenges and ongoing efforts in identifying effective Abeta aggregation inhibitors.
- To explore the relationship between Abeta species and their role in Alzheimer's disease development.
Main Methods:
- Literature review of existing research on Abeta aggregation.
- Analysis of structural and functional characteristics of different Abeta species.
- Discussion of current strategies for developing aggregation inhibitors.
Main Results:
- Abeta aggregation proceeds through various oligomeric and fibrillar states, many not yet characterized at a molecular level.
- The structural polymorphism of Abeta complicates the identification of specific inhibitors.
- The primary disease-causing Abeta species in Alzheimer's disease is not definitively established.
Conclusions:
- Understanding the detailed mechanisms of Abeta aggregation is crucial for therapeutic intervention.
- Developing selective and potent inhibitors targeting specific Abeta species presents significant challenges.
- Further research is needed to identify the key pathogenic Abeta species and develop effective Alzheimer's disease treatments.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:25Protein Folding
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
02:15Protein and Protein Structure
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...
A protein's shape is critical to its function. For example, an enzyme can...
01:13Protein Organization
Overview
03:00Molecular Chaperones and Protein Folding
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...